Trump 'fatigued,' receiving experimental drug cocktail

By Michael Hernandez

WASHINGTON (AA) - US President Donald Trump has received an experimental COVID-19 cocktail, but "remains fatigued" following his diagnosis, his personal physician announced Friday.

"As of this afternoon the president remains fatigued by in good spirits," Dr. Sean Conley said in a memo. "He's being evaluated by a team of experts, and together we'll be making recommendations to the President and First Lady in regards to next best steps."

First lady Melania Trump is currently suffering from a "mild cough and headache" while the remainder of the first family are "well" and have tested negative for the novel coronavirus, Conley added.

The president has been administered a single 8 gram dose of Regeneron Pharmaceutical's antibody cocktail, the physician said. The therapy is still in human trials, but is considered one of the most promising COVID-19 treatments.

Trump is also taking zinc, vitamin D, famotidine, melatonin, and a daily aspirin

Trump, who announced his diagnosis early Friday morning, is among those at highest risk for the virus' most dire health consequences. He is medically considered obese, and at 74 years old is elderly. Both groups are among those at highest risk for severe health consequences from COVID-19.

The president's announcement came hours after Hope Hicks, one of Trump's closest aides who traveled with him as recently as Wednesday evening, tested positive for the virus.

Trump has spent much of the year downplaying the severity of the virus, and has repeatedly appeared in public without a mask. Many of his family members and supporters declined to don them during Tuesday night's debate, violating the event's rules even as staff attempted to have audience members wear the protective face coverings.